← Back

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e.

Amount
up to $350,000
Type
Grant

Key facts

Key facts for NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Amountup to $350,000
IssuerNational Institutes of Health
Who can applyUS companies
SectorsHealthTech
DeadlineCloses 13 Nov 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

  1. 40 days agoagentImported from the official source
Opportunities with the same funding type or region
AI Growth LabCloses 27 Sep 2026
BJA FY 2026 Adult Treatment Court Programup to $2.5MCloses 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Casesup to $450,000Closes 29 Oct 2026